These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21107161)

  • 41. A case of moyamoya disease with progressive involvement from unilateral to bilateral.
    Matsushima T; Take S; Fujii K; Fukui M; Hasuo K; Kuwabara Y; Kitamura K
    Surg Neurol; 1988 Dec; 30(6):471-5. PubMed ID: 3265541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comment on "Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease".
    Esposito G; Fierstra J; Kronenburg A; Regli L
    Neurosurg Rev; 2012 Jan; 35(1):141-3; author reply 143. PubMed ID: 22101467
    [No Abstract]   [Full Text] [Related]  

  • 43. Moyamoya disease in children.
    Park TS
    Neurosurg Focus; 2008; 24(2):E16a; discussion E16a. PubMed ID: 18275293
    [No Abstract]   [Full Text] [Related]  

  • 44. Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease.
    Drouet C; Morel O; Thines L; Porot C; Boulahdour H
    Clin Nucl Med; 2017 May; 42(5):e269-e272. PubMed ID: 28221195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperventilation-enhanced chorea as a transient ischaemic phenomenon in a patient with moyamoya disease.
    Spengos K; Tsivgoulis G; Toulas P; Vemmos K; Vassilopoulos D; Spengos M
    Eur Neurol; 2004; 51(3):172-5. PubMed ID: 15079090
    [No Abstract]   [Full Text] [Related]  

  • 46. Occlusive cerebrovascular disease with moyamoya vessels and intracranial hemorrhage during pregnancy--case report and review of the literature.
    Hashimoto K; Fujii K; Nishimura K; Kibe M; Kishikawa T
    Neurol Med Chir (Tokyo); 1988 Jun; 28(6):588-93. PubMed ID: 2460789
    [No Abstract]   [Full Text] [Related]  

  • 47. Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.
    Hervé D; Ibos-Augé N; Calvière L; Rogan C; Labeyrie MA; Guichard JP; Godin O; Kossorotoff M; Habert MO; Lasserve ET; Chevret S; Chabriat H
    Neurology; 2019 Jul; 93(4):e388-e397. PubMed ID: 31239360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modern trends in diagnosis and surgical treatment of moyamoya disease].
    Shulgina AA; Lukshin VA; Korshunov AE; Belousova OB; Pronin IN; Usachev DY
    Zh Vopr Neirokhir Im N N Burdenko; 2020; 84(4):90-103. PubMed ID: 32759932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Management of Moyamoya Disease.
    Acker G; Fekonja L; Vajkoczy P
    Stroke; 2018 Feb; 49(2):476-482. PubMed ID: 29343587
    [No Abstract]   [Full Text] [Related]  

  • 50. Intraoperative monitoring in patients with moyamoya disease.
    Wong DH; McLeod DH
    Can J Anaesth; 1995 Nov; 42(11):1064-5. PubMed ID: 8590502
    [No Abstract]   [Full Text] [Related]  

  • 51. Stenotic changes of the posterior cerebral artery are a major contributing factor for cerebral infarction in moyamoya disease.
    Ohkura A; Negoto T; Aoki T; Noguchi K; Okamoto Y; Komatani H; Kawano T; Mukasa A; Morioka M
    Surg Neurol Int; 2018; 9():105. PubMed ID: 29930871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear medicine studies using pharmacologic intervention confirm both renovascular hypertension and improvement in cerebral perfusion after surgery in a child with moyamoya disease.
    Fiumara F; Louda C; Rossleigh MA; Rosenberg AR; Kainer G
    Clin Nucl Med; 2007 Feb; 32(2):110-3. PubMed ID: 17242563
    [No Abstract]   [Full Text] [Related]  

  • 53. Late-onset chorea after cerebral revascularization as a clinical manifestation of moyamoya disease.
    Enríquez-Ruano P; Navarro CE; Penagos N; Espitia OM
    Neurol Sci; 2021 Jul; 42(7):3027-3030. PubMed ID: 33751259
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cerebral hemodynamics in moyamoya disease. Significance of cerebral blood flow in relation to changes in arterial CO2 tension].
    Karasawa J; Kikuchi H; Nagata I; Naruo Y; Ihara I; Nakagawara J; Miyamoto S; Hashimoto K; Kuriyama Y
    Neurol Med Chir (Tokyo); 1986 Sep; 26(9):695-700. PubMed ID: 2433630
    [No Abstract]   [Full Text] [Related]  

  • 55. Moyamoya disease-induced hemichorea corrected by indirect bypass surgery.
    Kim YO; Kim TS; Woo YJ; Kim CJ; Oh CK
    Pediatr Int; 2006 Oct; 48(5):504-6. PubMed ID: 16970793
    [No Abstract]   [Full Text] [Related]  

  • 56. Reply to "mechanisms of postoperative progression of steno-occlusive lesions in the posterior cerebral artery in moyamoya disease".
    Lee JY; Wang KC
    Childs Nerv Syst; 2014 Apr; 30(4):559. PubMed ID: 24554085
    [No Abstract]   [Full Text] [Related]  

  • 57. Rethinking Cerebral Bypass Surgery.
    Rennert RC; Russin JJ
    Neurosurg Clin N Am; 2022 Oct; 33(4):403-417. PubMed ID: 36229128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment: Implications of non-moyamoya vessel formation in MCA steno-occlusive disease.
    Starke RM
    Neurology; 2016 May; 86(21):1962. PubMed ID: 27164685
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanisms of postoperative progression of steno-occlusive lesions in the posterior cerebral artery in moyamoya disease.
    Mugikura S; Takahashi S
    Childs Nerv Syst; 2014 Apr; 30(4):557-8. PubMed ID: 24557081
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of mesial temporal sclerosis and moyamoya syndrome.
    Gross BA; Ropper AE; Du R
    Clin Neurol Neurosurg; 2013 Jan; 115(1):106-7. PubMed ID: 22541517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.